Stockreport

FDA approves expansion of Nurix Therapeutics' phase 1 trial of NX-1607 into the U.S. [Seeking Alpha]

Nurix Therapeutics, Inc. - Common stock  (NRIX) 
PDF FDA approves expansion of Nurix Therapeutics' phase 1 trial of NX-1607 into the U.S.Jun. 30, 2022 9:12 AM ETNurix Therapeutics, Inc. ()By:Anuron MitraSA News EditorJHVEP [Read more]